---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-035866"
form_type: "8-K"
ticker: "SHPH"
cik: "0001757499"
company_name: "Shuttle Pharmaceuticals Holdings, Inc."
filed_at: "2022-12-19T23:59:59+00:00"
generated_at: "2026-06-21T02:37:27.457494+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Shuttle Pharma shareholders elect all six director nominees, ratify auditor at annual meeting

## Summary
- All six director nominees elected: Dritschilo (9,156,733 for), Brown (9,042,137), Senanayake (9,228,767), Richards (9,228,271), Schafer (9,227,021), Jacobs (9,040,276).
- Ratification of BF Borgers CPA, PC as independent auditor for FY2022 passed with 9,236,163 for, 133,785 against.
- Advisory vote on executive compensation approved: 9,009,757 for, 360,900 against.
- Advisory vote on frequency of executive compensation votes set at '1 year' with 9,129,620 votes (91.5% of votes cast).

## SEC filing metadata
- accession: 0001493152-22-035866
- form_type: 8-K
- ticker: SHPH
- cik: 0001757499
- company_name: Shuttle Pharmaceuticals Holdings, Inc.
- filed_at: 2022-12-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1757499/000149315222035866/0001493152-22-035866-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1757499/000149315222035866/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-035866
- JSON: https://secwatch.observer/filing/0001493152-22-035866.json
- Plain text: https://secwatch.observer/filing/0001493152-22-035866.txt

## Key facts
- Shareholder Votes
  Shuttle Pharmaceuticals Holdings, Inc. shareholders approved Approval of the Frequency of Advisory Votes on the Company's Executive Compensation at the 2022-12-16 meeting.
  - Proposal: say on pay frequency
  - Outcome: passed
  - Meeting: 2022-12-16
  source text: 4. Approval of the Frequency of Advisory Votes on the Company’s Executive Compensation. Shareholders voted (on an advisory basis) on the frequency with which to vote on the compensation of the Company’s executive officers, as set forth below. 1 Year 2 Year 3 Year Abstain 9,129,620 22,973 215,950 10,576
  evidence_url: https://www.sec.gov/Archives/edgar/data/1757499/000149315222035866/0001493152-22-035866-index.htm
- Shareholder Votes
  Shuttle Pharmaceuticals Holdings, Inc. shareholders approved Ratification of the Company's Independent Auditors at the 2022-12-16 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2022-12-16
  source text: 2. Ratification of the Company’s Independent Auditors. Shareholders ratified the appointment of BF Borgers CPA, PC as the Company’s independent auditors for the fiscal year ending December 31, 2022, in accordance with the voting results below. For Against Abstain Broker Non-Votes 9,236,163 133,785 9,171 -
  evidence_url: https://www.sec.gov/Archives/edgar/data/1757499/000149315222035866/0001493152-22-035866-index.htm
- Shareholder Votes
  Shuttle Pharmaceuticals Holdings, Inc. shareholders approved Approval of the Company's Executive Compensation at the 2022-12-16 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2022-12-16
  source text: 3. Approval of the Company’s Executive Compensation. Shareholders approved (on an advisory basis) the Company’s executive compensation. For Against Abstain Broker Non-Votes 9,009,757 360,900 8,462 -
  evidence_url: https://www.sec.gov/Archives/edgar/data/1757499/000149315222035866/0001493152-22-035866-index.htm
- Shareholder Votes
  Shuttle Pharmaceuticals Holdings, Inc. shareholders approved Election of Directors at the 2022-12-16 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2022-12-16
  source text: 1. Election of Directors. All of the following six nominees were elected to the Company’s Board of Directors, in accordance with the voting results listed below, to serve for a term of one year, until the next Annual Meeting and until their successors have been duly elected and have qualified. Nominee For Against Withheld Broker Non-Votes Anatoly Dritschilo, MD 9,156,733 - 222,386 - Milton Brown, MD, PhD 9,042,137 - 336,982 - Chris Senanayake, PhD 9,228,767 - 150,352 - Steven Richards 9,228,271 - 150,848 - Joshua Schafer 9,227,021 - 152,098 - Bette Jacobs, PhD 9,040,276 - 338,843 -
  evidence_url: https://www.sec.gov/Archives/edgar/data/1757499/000149315222035866/0001493152-22-035866-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.